What is EyeGuide?
EyeGuide, Inc. specializes in advanced brain health monitoring through its proprietary EyeGuide Focus system. This non-invasive eye-tracking test rapidly captures over 1,200 data points in just 10 seconds, offering a comprehensive evaluation of visual attention and overall wellness. The company's innovative platform serves a broad spectrum of clients, including healthcare systems, professional sports leagues, educational institutions, and community organizations across the United States and internationally. EyeGuide Focus provides objective data crucial for enhancing well-being and informing critical care and training decisions.
How much funding has EyeGuide raised?
EyeGuide has raised a total of $53K across 1 funding round:
Debt
$53K
Debt (2021): $53K with participation from PPP
Key Investors in EyeGuide
PPP
Public-Private Partnership
What's next for EyeGuide?
With the recent substantial expansion capital, EyeGuide is poised for significant scaling and market outreach. The company's strategic positioning at a Series B/C stage suggests a focus on broadening its customer base, enhancing product development, and potentially exploring new applications for its brain health monitoring technology. This investment will likely fuel efforts to solidify its presence in existing markets and expand its global footprint, further establishing EyeGuide as a leader in objective wellness assessment.
See full EyeGuide company page
